Industry payments to doctors drive surge in gabapentinoid prescribing, study finds

Drug makers’ payments to doctors have helped to drive the growing use of gabapentinoids, says a research letter in JAMA Internal Medicine.1The frequent off-label prescribing of this class of drugs…


Read Original Article: Industry payments to doctors drive surge in gabapentinoid prescribing, study finds »